drugset / Trial / NCT01370512
Droxidopa / Pyridostigmine in Orthostatic Hypotension
Phase 2
Enrolling by invitation
30 enrolled
Mayo Clinic
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study is being done to study the combination of pyridostigmine and low-dose Droxidopa for the treatment of orthostatic hypotension.
Timeline
- Start
- 2011-11
- Primary completion
- 2027-05
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Droxidopa | Small molecule | 100 mg | Oral |
| Subject | Pyridostigmine | Small molecule | 60 mg | Oral |